Nucleic Acids Research, 2000, Vol. 28, No. 20 3918-3925
© 2000 Oxford University Press
Activation of the BRLF1 promoter and lytic cycle of Epstein–Barr virus by histone acetylation
Molecular Genetics Laboratory, Department of Microbiology and Immunology, Chang-Gung University, Kwei-Shan, Taoyuan 333, Taiwan
Histone acetylation alters the chromatin structure and activates the genes that are repressed by histone deacetylation. This investigation demonstrates that treating P3HR1 cells with trichostatin A (TSA) activates the Epstein–Barr virus (EBV) lytic cycle, allowing the virus to synthesize three viral lytic proteins—Rta, Zta and EA-D. Experimental results indicate that TSA and 12-O-tetradecanoylphorbol-13-acetate synergistically activate the transcription of BRLF1, an immediate-early gene of EBV. Chromatin immunoprecipitation assay reveals that histone H4 at the BRLF1 promoter is acetylated after P3HR1 cells are treated with TSA, suggesting that histone acetylation activates BRLF1 transcription. Furthermore, results in this study demonstrate that mutation of a YY1-binding site in the BRLF1 promoter activates BRLF1 transcription 1.6- and 2.3-fold in P3HR1 cells and C33A cells, respectively. Real time PCR analysis reveals that the mutation also increases the histone acetylation level of the nucleosomes at the BRLF1 promoter 1.64- and 3.08-fold in P3HR1 and C33A cells, respectively. Results presented herein suggest that histone deacetylation plays an important role in maintaining the viral latency and histone acetylation at the BRLF1 promoter allows the virus to express Rta and to activate the viral lytic cycle.
* To whom correspondence should be addressed. Tel: +886 3 328 0292; Fax: +886 3 328 0292; Email: cgliu@mail.cgu.edu.tw
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. K. Countryman, L. Gradoville, and G. Miller Histone Hyperacetylation Occurs on Promoters of Lytic Cycle Regulatory Genes in Epstein-Barr Virus-Infected Cell Lines Which Are Refractory to Disruption of Latency by Histone Deacetylase Inhibitors J. Virol., May 15, 2008; 82(10): 4706 - 4719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-H. Lee, S.-S. Chang, S.-J. Lin, H.-H. Chua, T.-J. Tsai, K. Tsai, Y.-C. Lo, H.-C. Chen, and C.-H. Tsai Essential role of PKC{delta} in histone deacetylase inhibitor-induced Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells J. Gen. Virol., April 1, 2008; 89(4): 878 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-F. Chiu, C.-P. Tung, Y.-H. Lee, W.-H. Wang, C. Li, J.-Y. Hung, C.-Y. Wang, Y. Kawaguchi, and S.-T. Liu A comprehensive library of mutations of Epstein Barr virus J. Gen. Virol., September 1, 2007; 88(9): 2463 - 2472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Bhende, S. J. Dickerson, X. Sun, W.-H. Feng, and S. C. Kenney X-Box-Binding Protein 1 Activates Lytic Epstein-Barr Virus Gene Expression in Combination with Protein Kinase D J. Virol., July 15, 2007; 81(14): 7363 - 7370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Morris, R. R. Arnold, and J. Webster-Cyriaque Signaling Cascades Triggered by Bacterial Metabolic End Products during Reactivation of Kaposi's Sarcoma-Associated Herpesvirus J. Virol., June 1, 2007; 81(11): 6032 - 6042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. B. Kabotyanski, M. Huetter, W. Xian, M. Rijnkels, and J. M. Rosen Integration of Prolactin and Glucocorticoid Signaling at the {beta}-Casein Promoter and Enhancer by Ordered Recruitment of Specific Transcription Factors and Chromatin Modifiers Mol. Endocrinol., October 1, 2006; 20(10): 2355 - 2368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-K. Chang, J.-Y. Chung, Y.-R. Hong, T. Ichimura, M. Nakao, and S.-T. Liu Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1 Nucleic Acids Res., November 28, 2005; 33(20): 6528 - 6539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Walters, K. T. Hall, and A. Whitehouse The herpesvirus saimiri Rta gene autostimulates via binding to a non-consensus response element J. Gen. Virol., March 1, 2005; 86(3): 581 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-Y. Hsu, Y. Chang, P.-W. Wang, M.-Y. Liu, M.-R. Chen, J.-Y. Chen, and C.-H. Tsai Reactivation of Epstein-Barr virus can be triggered by an Rta protein mutated at the nuclear localization signal J. Gen. Virol., February 1, 2005; 86(2): 317 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Roychowdhury, R. A. Baiocchi, S. Vourganti, D. Bhatt, B. W. Blaser, A. G. Freud, J. Chou, C.-S. Chen, J. J. Xiao, M. Parthun, et al. Selective Efficacy of Depsipeptide in a Xenograft Model of Epstein-Barr Virus-Positive Lymphoproliferative Disorder J Natl Cancer Inst, October 6, 2004; 96(19): 1447 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-K. Chang, Y.-H. Lee, T.-S. Cheng, Y.-R. Hong, P.-J. Lu, J. J. Wang, W.-H. Wang, C.-W. Kuo, S. S.-L. Li, and S.-T. Liu Post-translational Modification of Rta of Epstein-Barr Virus by SUMO-1 J. Biol. Chem., September 10, 2004; 279(37): 38803 - 38812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Deng, C.-J. Chen, M. Chamberlin, F. Lu, G. A. Blobel, D. Speicher, L. A. Cirillo, K. S. Zaret, and P. M. Lieberman The CBP Bromodomain and Nucleosome Targeting Are Required for Zta-Directed Nucleosome Acetylation and Transcription Activation Mol. Cell. Biol., April 15, 2003; 23(8): 2633 - 2644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Thomas, K. Haleem, A. B. Siddique, W. J. Simmons, N. Sen, D.-J. Zhang, and V. K. Tsiagbe Regulation of Mouse Mammary Tumor Virus env Transcriptional Activator Initiated Mammary Tumor Virus Superantigen Transcripts in Lymphomas of SJL/J Mice: Role of Ikaros, Demethylation, and Chromatin Structural Change in the Transcriptional Activation of Mammary Tumor Virus Superantigen J. Immunol., January 1, 2003; 170(1): 218 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Tang and G. G. Maul Mouse Cytomegalovirus Immediate-Early Protein 1 Binds with Host Cell Repressors To Relieve Suppressive Effects on Viral Transcription and Replication during Lytic Infection J. Virol., December 20, 2002; 77(2): 1357 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. El-Guindy, L. Heston, Y. Endo, M.-S. Cho, and G. Miller Disruption of Epstein-Barr Virus Latency in the Absence of Phosphorylation of ZEBRA by Protein Kinase C J. Virol., October 11, 2002; 76(22): 11199 - 11208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gradoville, D. Kwa, A. El-Guindy, and G. Miller Protein Kinase C-Independent Activation of the Epstein-Barr Virus Lytic Cycle J. Virol., May 3, 2002; 76(11): 5612 - 5626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H. Niller, D. Salamon, J. Uhlig, S. Ranf, M. Granz, F. Schwarzmann, H. Wolf, and J. Minarovits Nucleoprotein Structure of Immediate-Early Promoters Zp and Rp and of oriLyt of Latent Epstein-Barr Virus Genomes J. Virol., March 19, 2002; 76(8): 4113 - 4118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-J. Chang and S.-T. Liu Function of the Intercistronic Region of BRLF1-BZLF1 Bicistronic mRNA in Translating the Zta Protein of Epstein-Barr Virus J. Virol., February 1, 2001; 75(3): 1142 - 1151. [Abstract] [Full Text]
|
|